Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605248
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-10
Brief Title:
NOTUS Feasibility Study Reducing Chronic Low Back Pain with Mobile App Intervention
Sponsor:
None
Organization:
None
Study Overview
Official Title:
NOTUS Feasibility Trial Enhancing Chronic Back Pain Management with Mobile App-based Pain Education and Clinical Hypnosis in Primary Care
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This feasibility study will investigate the feasibility of screening recruiting and delivering a mobile app intervention that involves pain education and clinical hypnosis to people seeking treatments for chronic low back pain chronic LBP in general practices in Australia
This study aims to assess the recruitment strategy the willingness of participants to be included in the proposed treatments whether the intervention can be delivered as intended within the health care system and clinical setting the adherence of participants to the proposed treatment response rates to questionnaires loss to the short-term follow-up and the appropriateness and acceptability of the interventions This feasibility study will inform possible modifications in the recruitment and treatments for the main clinical trial
A total of 60 participants will be randomised into two treatment groups
This study aims to assess the recruitment strategy the willingness of participants to be included in the proposed treatments whether the intervention can be delivered as intended within the health care system and clinical setting the adherence of participants to the proposed treatment response rates to questionnaires loss to the short-term follow-up and the appropriateness and acceptability of the interventions This feasibility study will inform possible modifications in the recruitment and treatments for the main clinical trial
A total of 60 participants will be randomised into two treatment groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None